Invention Grant
- Patent Title: Nanoparticle contrast agents for diagnostic imaging
- Patent Title (中): 用于诊断成像的纳米颗粒造影剂
-
Application No.: US15187115Application Date: 2016-06-20
-
Publication No.: US09585974B2Publication Date: 2017-03-07
- Inventor: Matthew David Butts , Robert Edgar Colborn , Peter John Bonitatibus, Jr. , Andrew Soliz Torres
- Applicant: General Electric Company
- Applicant Address: US NY Niskayuna
- Assignee: General Electric Company
- Current Assignee: General Electric Company
- Current Assignee Address: US NY Niskayuna
- Agent Paul J. DiConza
- Main IPC: A61K49/04
- IPC: A61K49/04 ; A61K49/10 ; A61K49/18 ; B82Y5/00

Abstract:
Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The nanoparticles have characteristics that result in minimal retention of the particles in the body compared to other nanoparticles. The nanoparticle comprising a nanoparticulate transition metal oxide covalently functionalized with a silane-functionalized non-targeting zwitterionic moiety.
Public/Granted literature
- US20160296641A1 NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING Public/Granted day:2016-10-13
Information query